Jack V. Pierce

3.4k total citations
52 papers, 2.3k citations indexed

About

Jack V. Pierce is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Jack V. Pierce has authored 52 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 17 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Jack V. Pierce's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (30 papers), Enzyme function and inhibition (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jack V. Pierce is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (30 papers), Enzyme function and inhibition (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jack V. Pierce collaborates with scholars based in United States, Norway and Italy. Jack V. Pierce's co-authors include Marion E. Webster, Kjell Nustad, John J. Pisano, Yoshio Hojima, Robert W. Colman, Allen P. Kaplan, Jorge A. Guimarães, Henry L. Meier, Cheryl F. Scott and Andranik Bagdasarian and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jack V. Pierce

52 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack V. Pierce United States 27 1.4k 787 520 254 253 52 2.3k
Thomas C. Detwiler United States 32 407 0.3× 917 1.2× 1.4k 2.6× 104 0.4× 533 2.1× 69 3.0k
Fakhri Mahdi United States 33 944 0.7× 1000 1.3× 613 1.2× 264 1.0× 175 0.7× 93 3.1k
Kulwant S. Aulak United States 31 348 0.2× 1.3k 1.7× 226 0.4× 220 0.9× 181 0.7× 61 3.0k
William H. Baricos United States 24 154 0.1× 897 1.1× 212 0.4× 79 0.3× 202 0.8× 44 3.1k
Silvina Epsztejn Israel 9 371 0.3× 522 0.7× 648 1.2× 640 2.5× 65 0.3× 9 1.6k
Michael Huang Australia 26 254 0.2× 1.5k 1.9× 496 1.0× 553 2.2× 227 0.9× 49 2.7k
Hans Goldenberg Austria 27 155 0.1× 931 1.2× 361 0.7× 542 2.1× 70 0.3× 93 2.0k
Or Kakhlon Israel 21 368 0.3× 724 0.9× 585 1.1× 560 2.2× 166 0.7× 41 1.9k
Gernot Bruchelt Germany 22 136 0.1× 653 0.8× 103 0.2× 233 0.9× 97 0.4× 85 1.5k
Gary Elliott United States 19 221 0.2× 493 0.6× 174 0.3× 35 0.1× 55 0.2× 52 1.6k

Countries citing papers authored by Jack V. Pierce

Since Specialization
Citations

This map shows the geographic impact of Jack V. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack V. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack V. Pierce more than expected).

Fields of papers citing papers by Jack V. Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack V. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack V. Pierce. The network helps show where Jack V. Pierce may publish in the future.

Co-authorship network of co-authors of Jack V. Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of Jack V. Pierce. A scholar is included among the top collaborators of Jack V. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack V. Pierce. Jack V. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansen, Liv, Kjell Nustad, Torill Berg, & Jack V. Pierce. (1984). Excess antibody immunoassay for rat glandular kallikrein. Measurement of kallikrein complexed with inhibitors and in plasma. Journal of Immunological Methods. 69(2). 253–266. 5 indexed citations
2.
Hojima, Yoshio, Jack V. Pierce, & John J. Pisano. (1982). Pumpkin seed inhibitor of human factor XIIa (activated Hageman factor) and bovine trypsin. Biochemistry. 21(16). 3741–3746. 50 indexed citations
3.
Lawton, William J., et al.. (1981). Characterization and origin of immunoreactive glandular kallikrein in rat plasma. Biochemical Pharmacology. 30(13). 1731–1737. 57 indexed citations
4.
Hojima, Yoshio, Donald L. Tankersley, Maggie Miller-Andersson, Jack V. Pierce, & John J. Pisano. (1980). Enzymatic properties of human hageman factor fragment with plasma prekallikrein and synthetic substrates. Thrombosis Research. 18(3-4). 417–430. 38 indexed citations
5.
Kettner, Charles A., Christopher K. Mirabelli, Jack V. Pierce, & Elliott Shaw. (1980). Active site mapping of human and rat urinary kallikreins by peptidyl chloromethyl ketones. Archives of Biochemistry and Biophysics. 202(2). 420–430. 38 indexed citations
6.
Hojima, Yoshio, Jack V. Pierce, & John J. Pisano. (1980). Plant inhibitors of serine proteinases: hageman factor fragment, kallikreins, plasmin, thrombin, factor Xa, trypsin, and chymotrypsin. Thrombosis Research. 20(2). 163–171. 27 indexed citations
7.
Proud, David, Jack V. Pierce, & John J. Pisano. (1980). Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.. PubMed. 95(4). 563–74. 47 indexed citations
8.
Pisano, John J., et al.. (1978). Kininogen in human urine. Inflammation Research. 8(1-2). 153–153. 13 indexed citations
9.
Scott, Cheryl F., et al.. (1977). Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.. Journal of Clinical Investigation. 60(1). 7–17. 33 indexed citations
10.
Webster, Marion E., Jorge A. Guimarães, Allen P. Kaplan, Robert W. Colman, & Jack V. Pierce. (1976). Activation of Surface-Bound Hageman Factor: Pre-Eminent Role of High Molecular Weight Kininogen and Evidence for a New Factor. Advances in experimental medicine and biology. 70(0). 285–299. 20 indexed citations
11.
Nustad, Kjell, et al.. (1975). SYNTHESIS OF KALLIKREINS BY RAT KIDNEY SLICES. British Journal of Pharmacology. 53(2). 229–234. 120 indexed citations
12.
Colman, Robert W., Andranik Bagdasarian, Richard C. Talamo, et al.. (1975). Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.. Journal of Clinical Investigation. 56(6). 1650–1662. 260 indexed citations
13.
Nustad, Kjell & Jack V. Pierce. (1974). Purification of rat urinary kallikreins and their specific antibody. Biochemistry. 13(11). 2312–2319. 112 indexed citations
14.
Webster, Marion E., et al.. (1973). Interaction of Hageman factor, prekallikrein activator and plasmin. Life Sciences. 13(9). 1201–1210. 7 indexed citations
15.
Pierce, Jack V., et al.. (1971). A sensitive isotopic procedure eor the assay oe esterase activity: measurement oe human urinary kaeeikrein. Clinica Chimica Acta. 32(1). 67–73. 110 indexed citations
16.
Pierce, Jack V. & Marion E. Webster. (1961). Human plasma kallidins: Isolation and chemical studies. Biochemical and Biophysical Research Communications. 5(5). 353–357. 100 indexed citations
17.
Webster, Marion E. & Jack V. Pierce. (1960). STUDIES ON PLASMA KALLIKREIN AND ITS RELATIONSHIP TO PLASMIN. Journal of Pharmacology and Experimental Therapeutics. 130(4). 484–491. 46 indexed citations
18.
Sarnoff, Stanley J., et al.. (1958). Observations on the Vasodilator Properties of Urine. Circulation Research. 6(4). 522–537. 24 indexed citations
19.
Brockman, John A., et al.. (1954). Proposed Structures for Protogen-A and Protogen-B. Journal of the American Chemical Society. 76(7). 1827–1828. 8 indexed citations
20.
Patterson, E. L., Jack V. Pierce, E. L. R. Stokstad, et al.. (1954). The Isolation of Protogen. Journal of the American Chemical Society. 76(7). 1823–1826. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas C. Detwiler Breakdown of academic impact, for papers by Fakhri Mahdi Breakdown of academic impact, for papers by Kulwant S. Aulak Breakdown of academic impact, for papers by William H. Baricos Breakdown of academic impact, for papers by Silvina Epsztejn Breakdown of academic impact, for papers by Michael Huang Breakdown of academic impact, for papers by Hans Goldenberg Breakdown of academic impact, for papers by Or Kakhlon Breakdown of academic impact, for papers by Gernot Bruchelt Breakdown of academic impact, for papers by Gary Elliott
Rankless by CCL
2026